Feb 16, 2022
Medable, a virtual trials provider, bought LEO Innovation’s Denmark-Based Omhu, which focuses on developing technology to address skin conditions.
seen from Malaysia
seen from Nepal
seen from Malaysia
seen from Brazil
seen from Egypt
seen from China
seen from Germany
seen from United States
seen from United Kingdom
seen from Israel
seen from Egypt
seen from United States
seen from Türkiye
seen from United States
seen from United States
seen from United States
seen from Yemen
seen from Bangladesh
seen from Lithuania
seen from China
Medable, a virtual trials provider, bought LEO Innovation’s Denmark-Based Omhu, which focuses on developing technology to address skin conditions.
Medable Inc., a leading software provider for patient-centered clinical trials, today announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
Digital clinical trial platform Medable landed a whopping $304 million in a Series D funding round led by Blackstone Growth, Tiger Global and GSR ventures. Sapphire Ventures and WTI also participated.
Medable from ILLO
This is about to be the best sucker in the world. #medable #highlife #medicalmarijuana #420